期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

如何选择治疗晚期肾癌的靶向药物? 被引量：5

How to select targeted agents for advanced kidney cancer?
下载PDF
导出
摘要 肾癌是近年来靶向药物应用最成功的领域之一,被批准用于晚期肾癌的靶向药物已有5种之多。如何行之有效地运用这些药物,是临床急需解决的问题。本文就循证医学证据、药物自身特点、患者具体情况和国情等,综述晚期肾癌靶向药物的一线选择和合理的有序选择。 Kidney cancer is one of the most successful field of targeted therapy recently. Five agents have been approved to treat advanced kidney cancer. But it＇s a big problem to clinicians that how to use these agents effectively. This article aimed to detail first, reasonable and sequential selections of targeted agents in advanced kidney cancer according to medical evidences, agents＇ characteristics, individual status and country conditions.
作者 郭军
机构地区 北京大学临床肿瘤学院北京肿瘤医院暨北京市肿瘤防治研究所肾癌黑色素瘤内科 北京肿瘤医院恶性肿瘤发病机制及转化研究教育部重点实验室
出处 《临床肿瘤学杂志》 CAS 2009年第7期577-584,共8页 Chinese Clinical Oncology
关键词 晚期肾癌 靶向药物 Advanced kidney cancer Targeted agents
分类号 R737.11 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献24

  • 1Jemal A,Clegg LX,Ward E,et al.Annual report to the nation on the status of cancer,1975～2001,with a special feature regarding survival[J].Cancer,2004,101(1):3-27.
  • 2Janzen NK,Kim HL,Figlin RA,et al.Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease[J].Urol Clin North Am,2003,30(4):843-852.
  • 3Fisher RI,Rosenberg SA,Fyfe G.Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.Cancer[J].J Sci Am,2000,6 (Suppl 1):55-57.
  • 4Coppin C,Porzsolt F,Kumpf J,et al.Immunotherapy for advanced renal cell cancer[J].Cochrane Database Syst Rev,2000,(3):CD001425.
  • 5Escudier B,Eisen T,Stadler WM,et al.Sorafenib in advanced clear-cell renal-cell carcinoma[J].N Engl J Med,2007,356(2):125-134.
  • 6George CM,Stadler WM.The role of systemic chemotherapy in the treatment of kidney cancer[A].Figlin R.Kidney Cancer[M].Norwell MA:Kluwer Academic Publishers,2003.
  • 7McDermott DF,Regan MM,Clark JI,et al.Randomized phase Ⅲ trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma[J].J Clin Oncol,2005,23(1):133-141.
  • 8Stadler WM,Halabi S,Rini B,et al.Cancer and Leukemia Group B.A phase Ⅱ study of gemcitabine and capecitabine in metastatic renal cancer:a report of Cancer and Leukemia Group B protocol 90008[J].Cancer,2006,107(6):1273-1279.
  • 9Motzer RJ,Rini BI,Bukowski RM,et al.Sunitinib in patients with metastatic renal cell carcinoma[J].JAMA,2006,295(21):2516-2524.
  • 10Schmidt-Wolf IG,Negrin RS,Kiem HP,et al.Use of a SCID mouse/human lymphoma model to evaluate cytokinE-induced killer cells with potent antitumor cell activity[J].J Exp Med,1991,174(1):139-149.

共引文献24

同被引文献83

  • 1彭宝岗,梁力建,何强,黎剑,吕明德.选择性扩增人自然杀伤细胞的实验研究[J].癌症,2005,24(10):1287-1289. 被引量：4
  • 2李晓红,马健,汪菲菲,窦立萍,李猛,高春记.体外扩增高纯度的人外周血来源的NK细胞的研究[J].中国实验血液学杂志,2007,15(2):373-377. 被引量：15
  • 3Rock EP, Goodman V, Jiang JX, et al. Food and Drug Ad- ministration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced re- nal cell carcinoma[J]. Oncologist,2007,12(1):107-113.
  • 4Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy[J]. J Pharmacol Exp Ther, 2005,315(3) 971-979.
  • 5Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal cell carcinoma[J]. N Engl J Med,2007,356(2) :115-124.
  • 6Figlin RA, Hutson TE, Tomczak MD, et al. Overall surviv- al with sunitinib versus interferon (IFN)-alfa as first-llne treatment of metastatic renal cell carcinoma (mRCC) [J]. J Clin Oncol, 2008,26 (Suppl) : 5024-5028.
  • 7Pitino A,Squillaci S, Spairani C, et al. Primary synovialsarcoma of the kidney. A case report with pathologic appraisalinvestigation and literature review [J]. Pathologica, 2011,103(5):271-278.
  • 8Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61(2): 69-90.
  • 9Lindblad P. Epidemiology of renal cell carcinoma [J]. ScandJ Surg,2004, 93 (2): 88-96.
  • 10Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renalcell cancer-a quantitative review [J]. Br J Cancer, 2001,85(7): 984-990.

引证文献5

二级引证文献13

临床肿瘤学杂志
2009年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部